Tue, Dec 23, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Mixed feelings about 'Tobin’ tax

Friday, January 13, 2012

Benedicte Gravrand, Opalesque Geneva:

There’s been a lot of commotion since the European Commission, in September 2011, released a Directive to put in place a Financial Transaction Tax (FTT). While MEPs seem more ready than ever to vote for the implementation of the tax, some experts warn of its potential "devastating" or "seismic" effects on the markets.

The latest reaction is a letter from EDHEC to the French Prime Minister, reminding him of the potential effect of such a tax – especially since the French government is planning to go ahead with it without waiting for the EU's go ahead.

EDHEC-Risk Institute sent a letter to French Prime Minister François Fillon on Tuesday, to appeal against the plans announced by French President Sarkozy earlier this month, to establish a financial transaction tax – aka a Tobin tax – this spring.

EDHEC-Risk Institute is part of EDHEC Business School, one of Europe’s leading business schools. The Institute had already sent a letter to the European Commission in July last year, complete with a research report on the effect of such a tax, advising a debate on the matter before making any decision.

"By deciding not to wait for the conclusion of this debate and by planning for France, without its European partners, to push ahead with the imposition of such a tax on......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its